[theflyonthewall.com] - Dendreon is working with JPMorgan to solicit takeover offers after sales of its cancer treatment Provenge failed to meet expectations, reports Bloomberg, citing people familiar with the matter.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment